XML 49 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
9 Months Ended
Sep. 30, 2013
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES  
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES

NOTE 2. CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES

 

Securities classified as cash and cash equivalents and available-for-sale marketable securities as of September 30, 2013 and December 31, 2012 are summarized below (in thousands). Estimated fair value is based on quoted market prices for these investments.

 

 

 

 

 

Gross

 

Gross

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

 

 

September 30, 2013

 

Cost

 

Gains

 

Losses

 

Fair Value

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

Cash

 

$

28,050

 

$

 

$

 

$

28,050

 

Money market funds

 

36,232

 

 

 

36,232

 

Total cash and cash equivalents

 

64,282

 

 

 

64,282

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

Total maturing within 1 year and included in marketable securities:

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

13,082

 

8

 

(2

)

13,088

 

U.S. government agency debt securities

 

3,203

 

3

 

 

3,206

 

Total maturing between 1 and 2 years and included in marketable securities:

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

4,782

 

5

 

(1

)

4,786

 

Total available-for-sale securities

 

21,067

 

16

 

(3

)

21,080

 

 

 

 

 

 

 

 

 

 

 

Total cash, cash equivalents and marketable securities

 

$

85,349

 

$

16

 

$

(3

)

$

85,362

 

 

 

 

 

 

Gross

 

Gross

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

 

 

December 31, 2012

 

Cost

 

Gains

 

Losses

 

Fair Value

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

Cash

 

$

11,769

 

$

 

$

 

$

11,769

 

Money market funds

 

11,268

 

 

 

11,268

 

Corporate debt securities

 

6,039

 

 

 

6,039

 

Total cash and cash equivalents

 

29,076

 

 

 

29,076

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

Total maturing within 1 year and included in marketable securities:

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

21,662

 

31

 

 

21,693

 

U.S. government agency debt securities

 

14,027

 

8

 

 

14,035

 

U.S. Treasury securities

 

2,008

 

1

 

 

2,009

 

Total maturing between 1 and 2 years and included in marketable securities:

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

7,858

 

7

 

(2

)

7,863

 

U.S. government agency debt securities

 

3,208

 

8

 

 

3,216

 

Total available-for-sale securities

 

48,763

 

55

 

(2

)

$

48,816

 

 

 

 

 

 

 

 

 

 

 

Total cash, cash equivalents and marketable securities

 

$

77,839

 

$

55

 

$

(2

)

$

77,892

 

 

The Company considers all highly liquid investments with a maturity at date of purchase of three months or less to be cash equivalents. The Company places its cash, cash equivalents and marketable securities with U.S. Treasury and government agency securities, and high quality securities of U.S. and international financial and commercial institutions, To date, the Company has not experienced material losses on any of its balances. All marketable securities are classified as available-for-sale since these instruments are readily marketable. These securities are carried at fair value, which is based on readily available market information, with unrealized gains and losses included in accumulated other comprehensive gain (loss) within shareholders’ equity. The Company uses the specific identification method to determine the amount of realized gains or losses on sales of marketable securities. Realized gains or losses have been insignificant and are included in “interest and other income” in the condensed statement of operations.

 

At September 30, 2013, the Company had 10 securities in an unrealized loss position. The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at September 30, 2013 (in thousands):

 

 

 

Less than 12 months

 

12 months or greater

 

Total

 

 

 

 

 

Gross

 

 

 

Gross

 

 

 

Gross

 

 

 

 

 

Unrealized

 

 

 

Unrealized

 

 

 

Unrealized

 

 

 

Fair Value

 

Losses

 

Fair Value

 

Losses

 

Fair Value

 

Losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

4,164

 

$

(3

)

$

 

$

 

$

4,164

 

$

(3

)

 

The gross unrealized losses above were caused by interest rate increases. No significant facts or circumstances have arisen to indicate that there has been any deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company’s review of these securities, including the assessment of the duration and severity of the unrealized losses and the Company’s ability and intent to hold the investments until maturity, there were no material other-than-temporary impairments for these securities at September 30, 2013.

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.

 

The Company utilizes the following fair value hierarchy based on three levels of inputs:

 

·                  Level 1: Quoted prices in active markets for identical assets or liabilities.

·                  Level 2: Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

·                  Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

The following tables represent the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2013 and December 31, 2012 (in thousands):

 

September 30, 2013

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Money market funds

 

$

36,232

 

$

 

$

 

$

36,232

 

Corporate debt securities

 

 

17,874

 

 

17,874

 

Government agency debt securities

 

 

3,206

 

 

3,206

 

Total

 

$

36,232

 

$

21,080

 

$

 

$

57,312

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Contingent consideration- Zipsor

 

 

 

 

 

1,539

 

1,539

 

Contingent consideration- Lazanda

 

 

 

 

 

8,248

 

8,248

 

Total

 

$

 

$

 

$

9,787

 

$

9,787

 

 

The fair value measurement of the contingent consideration obligations arises from the Lazanda and Zipsor acquisitions and relates to the potential future milestone payments and royalties under the respective agreements which are determined using Level 3 inputs. The key assumptions in determining the fair value are the discount rate and the probability assigned to the potential milestones and royalties being achieved. At each reporting date, the Company will re-measure the contingent consideration obligation arising from both acquisitions to its estimated fair value. Changes in the fair value of the contingent consideration obligations are recorded as a component of operating income in our condensed statement of operations and comprehensive income. For the three and nine months ended September 30, 2013, accretion expense of $0.3 and $0.4 million was included within interest and other expense in the accompanying condensed statement of operations.

 

The table below provides a summary of the changes in fair value of all financial liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended September 30, 2013 (in thousands):

 

 

 

Balance at

 

Acquisition

 

Net accretion

 

Balance at

 

 

 

December 31,

 

July 29,

 

and fair value

 

September 30,

 

 

 

2012

 

2013

 

adjustments

 

2013

 

Liabilities:

 

 

 

 

 

 

 

 

 

Contingent consideration obligations- Zipsor

 

$

1,342

 

$

 

$

197

 

$

1,539

 

Contingent consideration obligations- Lazanda

 

$

 

$

8,004

 

$

244

 

$

8,248

 

Total

 

$

1,342

 

$

8,004

 

$

441

 

$

9,787